GB0023902D0 - Therapeutically useful compounds - Google Patents

Therapeutically useful compounds

Info

Publication number
GB0023902D0
GB0023902D0 GB0023902A GB0023902A GB0023902D0 GB 0023902 D0 GB0023902 D0 GB 0023902D0 GB 0023902 A GB0023902 A GB 0023902A GB 0023902 A GB0023902 A GB 0023902A GB 0023902 D0 GB0023902 D0 GB 0023902D0
Authority
GB
United Kingdom
Prior art keywords
therapeutically useful
useful compounds
compounds
therapeutically
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0023902A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0023902A priority Critical patent/GB0023902D0/en
Publication of GB0023902D0 publication Critical patent/GB0023902D0/en
Priority to EP01970023.6A priority patent/EP1324990B1/en
Priority to AU2001290143A priority patent/AU2001290143A1/en
Priority to ARP010104602A priority patent/AR035205A1/en
Priority to JP2002531106A priority patent/JP5089846B2/en
Priority to KR10-2003-7004594A priority patent/KR20030031198A/en
Priority to PL01362711A priority patent/PL362711A1/en
Priority to ES01970023.6T priority patent/ES2527688T3/en
Priority to PCT/GB2001/004345 priority patent/WO2002026722A1/en
Priority to IL15509301A priority patent/IL155093A0/en
Priority to HU0302302A priority patent/HUP0302302A2/en
Priority to CA002423251A priority patent/CA2423251A1/en
Priority to MXPA03002814A priority patent/MXPA03002814A/en
Priority to BR0114323-9A priority patent/BR0114323A/en
Priority to NZ525056A priority patent/NZ525056A/en
Priority to US10/381,767 priority patent/US7101882B2/en
Priority to CNA018196365A priority patent/CN1678594A/en
Priority to CZ20031195A priority patent/CZ20031195A3/en
Priority to US10/509,519 priority patent/US20050222147A1/en
Priority to ZA200302411A priority patent/ZA200302411B/en
Priority to NO20031442A priority patent/NO20031442L/en
Priority to US11/284,544 priority patent/US7560548B2/en
Priority to US12/391,855 priority patent/US20090163495A1/en
Ceased legal-status Critical Current

Links

GB0023902A 2000-09-29 2000-09-29 Therapeutically useful compounds Ceased GB0023902D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB0023902A GB0023902D0 (en) 2000-09-29 2000-09-29 Therapeutically useful compounds
CZ20031195A CZ20031195A3 (en) 2000-09-29 2001-09-28 Morpholinoacetamide derivatives
HU0302302A HUP0302302A2 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseses, process for their preparation and pharmaceutical compositions containing them
MXPA03002814A MXPA03002814A (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases.
ARP010104602A AR035205A1 (en) 2000-09-29 2001-09-28 USEFUL COMPOUNDS IN THE TREATMENT OF INFLAMMATORY DISEASES, PROCESS FOR PREPARATION, INTERMEDIARIES AND PHARMACEUTICAL COMPOSITIONS
JP2002531106A JP5089846B2 (en) 2000-09-29 2001-09-28 Morpholine-acetamide derivatives for treating inflammatory diseases
KR10-2003-7004594A KR20030031198A (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
PL01362711A PL362711A1 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
ES01970023.6T ES2527688T3 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
PCT/GB2001/004345 WO2002026722A1 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
IL15509301A IL155093A0 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment on inflammatory diseases
EP01970023.6A EP1324990B1 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
CA002423251A CA2423251A1 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2001290143A AU2001290143A1 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
BR0114323-9A BR0114323A (en) 2000-09-29 2001-09-28 Compound or a pharmaceutically acceptable salt or solvate thereof, pharmaceutical composition, use of the compound or a pharmaceutically acceptable salt or solvate thereof, method of treating or prophylaxis of inflammatory diseases, and process for preparing the compound
NZ525056A NZ525056A (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
US10/381,767 US7101882B2 (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
CNA018196365A CN1678594A (en) 2000-09-29 2001-09-28 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
ZA200302411A ZA200302411B (en) 2000-09-29 2003-03-27 Morpholin-acetamide derivatives for the treatment of inflammatory diseases.
US10/509,519 US20050222147A1 (en) 2000-09-29 2003-03-27 Process for the preparation of morpholine derivatives and intermediates therefore
NO20031442A NO20031442L (en) 2000-09-29 2003-03-28 Morpholine-acetamide derivatives for the treatment of inflammatory diseases
US11/284,544 US7560548B2 (en) 2000-09-29 2005-11-22 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
US12/391,855 US20090163495A1 (en) 2000-09-29 2009-02-24 Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0023902A GB0023902D0 (en) 2000-09-29 2000-09-29 Therapeutically useful compounds

Publications (1)

Publication Number Publication Date
GB0023902D0 true GB0023902D0 (en) 2000-11-15

Family

ID=9900382

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0023902A Ceased GB0023902D0 (en) 2000-09-29 2000-09-29 Therapeutically useful compounds

Country Status (2)

Country Link
GB (1) GB0023902D0 (en)
ZA (1) ZA200302411B (en)

Also Published As

Publication number Publication date
ZA200302411B (en) 2004-07-05

Similar Documents

Publication Publication Date Title
EP1349851A4 (en) Compounds
AU2405002A (en) Dehalogeno compounds
GB0023973D0 (en) Therapeutically useful compounds
GB0023902D0 (en) Therapeutically useful compounds
GB0029579D0 (en) Therapeutically useful compounds
GB0030915D0 (en) Therapeutically useful compounds
GB0111642D0 (en) Therapeutically useful compounds
GB0127159D0 (en) Therapeutically useful compounds
GB0125123D0 (en) Therapeutically useful compounds
GB0117145D0 (en) Therapeutically useful compounds
GB0111645D0 (en) Therapeutically useful compounds
GB0109999D0 (en) Therapeutically useful compounds
GB0107644D0 (en) Therapeutically useful compounds
GB0107643D0 (en) Therapeutically useful compounds
GB9915542D0 (en) Therapeutically useful compounds
HU0402189D0 (en) Intermediate compounds
GB0006454D0 (en) Compounds
GB0005387D0 (en) Compounds
GB0003637D0 (en) Compounds
GB0003634D0 (en) Compounds
GB0003633D0 (en) Compounds
GB0003631D0 (en) Compounds
GB0003609D0 (en) Compounds
GB0003608D0 (en) Compounds
GB0003600D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)